Results 101 to 110 of about 195,940 (363)
Stent implantation in a left ventricular assist device
REC: Interventional Cardiology (English Ed.), 2020 Sixty-eight-year-old male patient carrier of one HeartWare left ventricular assist device as destination therapy due to ischemic dilated cardiomyopathy.
Raquel Álvarez Ramos +2 more
doaj +1 more source
Advanced Science, EarlyView.This review explores the cutting‐edge development of bio‐integrated flexible electronics for real‐time hemodynamic monitoring in cardiovascular healthcare. It covers key physiological indicators, innovative sensing mechanisms, and materials considerations. This paper highlights the application of both invasive and non‐invasive devices in cardiovascular
Ke Huang, Zhiqiang Ma, Bee Luan Khoo
wiley +1 more source
Cavopulmonary assist for the failing Fontan circulation: impact of ventricular function on mechanical support strategy [PDF]
, 2014 Mechanical circulatory support--either ventricular assist device (VAD, left-sided systemic support) or cavopulmonary assist device (CPAD, right-sided support)--has been suggested as treatment for Fontan failure.
Chen, Jun +6 more
core +1 more source
ASAIO Journal, 2019 Neurologic events occur in up to 18% of patients with continuous-flow left ventricular assist devices (LVAD) and is associated with significant morbidity and mortality. The current form of the LVAD equipment is not suited to serve patients who are impaired by a stroke.
Cees W. van der Heiden +6 more
openaire +5 more sources
Metal–Organic Frameworks: Unlocking New Frontiers in Cardiovascular Diagnosis and Therapy
Advanced Science, EarlyView.Metal–organic frameworks (MOFs), are composed of metal ions and bridging organic ligands, are recognized as an excellent platform for host‐gust chemistry. Its rich structural composition, modifiable sites, and multilevel pore distribution can provide delivery and release of signaling molecules, probes, and therapeutic drugs, which exhibit great medical
Qilu Wu +6 more
wiley +1 more source
Occupational Therapy’s Role with Ventricular Assist Devices and the Promotion of Travel Protocols [PDF]
, 2020 An option for individuals diagnosed with end-stage heart failure is to receive a ventricular assist device (VAD). In 2006, Shepherd and Wilding produced an article regarding occupational therapy’s role during the VAD process as they anticipated a growing
Chandra, Natasha, Suplicki, Linda
core +1 more source
Minimally invasive implantation of continuous flow left ventricular assist devices: the evolution of surgical techniques in a single centre experience [PDF]
, 2018 To evaluate the evolution of our surgical experience with the implantation of a continuous flow left ventricular assist device (LVAD), from the original full sternotomy approach to less invasive surgical strategies including mini-sternotomy and/or mini ...
Bejko, Jonida +8 more
core +1 more source
Advanced Science, EarlyView.Cardiomyocyte‐enriched USP20 regulates the K63‐linked ubiquitination of STAT3, and the cardiomyocyte‐specific USP20‐STAT3‐CARM1 axis exerts a protective role in cardiac hypertrophy. Targeting USP20 through cardiac‐specific gene therapy presents a promising strategy for the treatment of cardiac hypertrophy.
Lingfeng Zhong +15 more
wiley +1 more source
Synergistic effect of shear and ADP on platelet growth on ZTA and Ti6Al4V surfaces [PDF]
arXiv, 2020 Continuous-flow ventricular assist devices (VADs) have been an increasingly common, life-saving therapy for advanced heart-failure patients, but elevate the risk of thrombosis due to a combination of non-physiological hemodynamics and synthetic biomaterials.
arxiv
The effect of transfusion of blood products on ventricular assist device support outcomes
ESC Heart Failure, 2020 Aims Perioperative blood transfusions are common among patients undergoing left ventricular assist device (LVAD) implantation. The association between blood product transfusion at the time of LVAD implantation and mortality has not been described ...
Supriya Shore +16 more
doaj +1 more source